Oligosaccharides interfere with the establishment and progression of experimental pneumococcal pneumonia

Journal of Infectious Diseases

Volumn 176, Issue 3, 1997, Pages 704-712

  Idänpään Heikkilä, Ilona ^b   Simon, Paul M ^b   Zopf, David ^b   Vullo, Thomas ^b   Cahill, Patrick ^b   Sokol, Karen ^b   Tuomanen, Elaine ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

2 (3 METHOXY 5 METHYLSULFONYL 4 PROPOXYPHENYL) 5 (3,4,5 TRIMETHOXYPHENYL)TETRAHYDROFURAN; GLYCOCONJUGATE; MONOCLONAL ANTIBODY; OLIGOSACCHARIDE; SIALIC ACID DERIVATIVE; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTEREMIA; BACTERIAL COLONIZATION; BACTERIUM ADHERENCE; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFICACY; HUMAN; HUMAN CELL; INTRANASAL DRUG ADMINISTRATION; INTRATRACHEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LOBAR PNEUMONIA; LUNG ALVEOLUS EPITHELIUM; LUNG EDEMA; LUNG LAVAGE; NASOPHARYNX; NONHUMAN; PRIORITY JOURNAL; RABBIT; RAT; SIALYLATION;

EID: 0030807607     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/514094     Document Type: Article

References (20)

1. Zopf D, Roth S. Oligosaccharide anti-infective agents. Lancet 1996;347: 1017-21.
2. Aaronson M, Medalia O, Schori L, Mirelman D, Sharon N, Ofek I. Prevention of colonization of the urinary tract of mice with Escherichia coli by blocking of bacterial adherence with methyl alpha-D-mannopyranoside. J Infect Dis 1979;139:329-32.
3. Roberts J, Marklund B, Ilver D, et al. The Gal α1-4 Gal specific tip adhesin of Escherichia coli P-fimbriae is needed for pyelonephritis to occur in the normal urinary tract. Proc Natl Acad Sci USA 1994;91: 11889-93.
4. Svanborg Eden C, Freter R, Hagbert L, et al. Inhibition of experimental ascending urinary tract infection by an epithelial cell surface receptor analog. Nature 1982;298:560-2.
5. Tuomanen E, Towbin H, Rosenfelder G, et al. Receptor analogs and monoclonal antibodies which inhibit adherence of Bordetella pertussis to human ciliated respiratory epithelial cells. J Exp Med 1988;168:267-77.
6. Andersson B, Dahmen J, Frejg T, et al. Identification of an active disaccharide unit of a glycoconjugate receptor for pneumococci attaching to human pharyngeal epithelial cells. J Exp Med 1983;158:559-70.
7. Tuomanen E, Masure R. The molecular and cellular basis of pneumococcal infection. Microbial Drug Resistance 1997;8 (in press).
8. Krivan HC, Roberts DD, Ginsburg V. Many pulmonary pathogenic bacteria bind specifically to the carbohydrate sequence GalNac β1-4 Gal found in some glycolipids. Proc Natl Acad Sci USA 1988;85:6157-61.
9. Sundberg-Kovamees M, Holme T, Sjogren A. Specificity of binding of Streptococcus pneumoniae to two receptor saccharide structures. Microb Pathog 1994;17:63-8.
10. Cundell D, Tuomanen E. Receptor specificity of adherence of Streptococcus pneumoniae to human type II pneumocytes and vascular endothelial cells in vitro. Microb Pathog 1994;17:361-74.
11. Cundell D, Gerard N, Gerard C, Idänpään-Heikkilä I, Tuomanen E. Streptococcus pneumoniae anchors to activated eukaryotic cells by the receptor for platelet activating factor. Nature 1995;377:435-8.
12. Geelen S, Battacharyya C, Tuomanen E. Cell wall mediates pneumococcal attachment and cytopathology to human endothelial cells. Infect Immun 1993;61:1538-43.
13. Zopf DA, Tsai CM, Ginzburg V. Carbohydrate antigens: coupling of oligosaccharide-phenylthylamine-isothiocyanate derivatives to bovine serum albumin. Methods Enzymol 1978;50:1017-21.
14. Cabellos C, MacIntyre DE, Forrest M, Burroughs M, Prasad S, Tuomanen E. Differing roles of platelet-activating factor during inflammation of the lung and subarachnoid space. J Clin Invest 1992;90:612-8.
15. Cutillo A, Morris A, Blatter D, et al. Determination of lung water content and distribution by nuclear magnetic resonance. J Appl Physiol 1984; 57:583-8.
16. Weiser J, Austrian R, Sreenivasan P, Masure H. Phase variation in pneumococcal opacity: relationship between colonial morphology and nasopharyngeal colonization. Infect Immun 1994;62:2582-9.
17. + T-cell subsets. Proc Natl Acad Sci USA 1994;91:18-22.
18. Jennings M, Hood D, Peak I, Virji M, Moxon E. Molecular analysis of a locus for the biosynthesis and phase-variable expression of the lacto-N-neotetraose terminal lipopolysaccharide structure in Neisseria meningitidis. Mol Microbiol 1995;18:729-40.
19. Klein N, Ison C, Peakman M, et al. The influence of capsulation and lipooligosaccharide structure on neutrophil adhesion molecule expression and endothelial injury by Neisseria meningitidis. J Infect Dis 1996; 173:172-9.
20. Kunz C, Rudloff S. Biological function of oligosaccharides in human milk. Acta Paediatr 1993;82:903-12.